ArticleFood chemistry: X2026
Separation of saponins from quinoa bran by a novel single-column three-stage foam fractionation technology.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed a novel single-column three-stage foam fractionation technology to separate saponins from quinoa bran. For efficient separating saponins from their highly concentrated aqueous solution (300 mg/L), large bubbles, multi-layered foam and small bubbles performed their own specific functions to achieve a high enrichment ratio of 7.1 and a high recovery percentage of 91.7%, respectively. Multi-layered foam could strengthen the foam drainage with a low liquid holdup of 0.5% and enhance the foam stability with a high half-life of 630 s simultaneously. FTIR and HPLC-MS were performed to analyze and characterize the ingredients of the product (mainly are triterpenoid saponins) and the purity of total saponins (91.9%). This work is expected to provide a simple and highly-efficient technology for the separation of natural surface-active substances and facilitate the industrial application of foam fractionation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.